leuprolide + goserelin

Leuprolide and goserelin are both gonadotropin-releasing hormone (GnRH) agonists used in similar clinical contexts. While they're not typically formulated together as a single product, they represent alternative treatment options for the same conditions. ## Mechanism of Action Both medications work by initially stimulating and then suppressing the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland. This leads to decreased production of sex hormones - testosterone in men and estrogen in women. After 2-4 weeks of treatment, continuous stimulation results in feedback inhibition and significant downregulation of these hormones, producing therapeutic benefits. ## Clinical Uses These medications are primarily used for: 1. **Prostate Cancer**: Both are effective in achieving castration levels in metastatic prostate cancer patients. 2. **Breast Cancer**: Used in the treatment of hormone-responsive breast cancer, particularly in pre- and perimenopausal women. 3. **Endometriosis**: Both medications effectively manage endometriosis by reducing estrogen levels. 4. **Other Conditions**: They're also used for uterine fibroids, precocious puberty (leuprolide), and as part of transgender hormone therapy.

Other names

leuprorelin + goserelin